Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Non Comparative, Prospective Pilot Study, to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD

NCT00324532 is registered in ClinicalTrials.gov with BioBalance Corporation as lead sponsor.

NCT NCT00324532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00324532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Non Comparative, Prospective Pilot Study, to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD
Lead sponsor
BioBalance Corporation
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
May 31, 2007
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gerd